Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00550654 · OUTCOME

12 Month Local Control in All Sites of Treatment, and at Each Site of Treatment

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain · Source last updated 2017-01-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
12 months

What was measured

Local control (e.g. absence of local progression) is defined as Complete response (CR), partial response (PR) or stable disease (SD) of the treated site(s). Complete response is the disappearance of the target lesion. Partial response is a \>/= 50% decrease in maximal dimension compared to pretreatment imaging. Stable disease does not qualify for CR, PR, or progression. Progression is an interval increase in the maximal dimension of the target lesion.

Analysis population: No data/specimens were collected. Study was terminated due to poor accrual.

Groups in this outcome

Radiation Therapy in Metastatic Cancer

Patients undergo hypofractionated highly conformal radiotherapy with helical tomotherapy once every other day over 5 days for a total of 3 fractions.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Radiation Therapy in Metastatic Cancer0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
Local control (e.g. absence of local progression) is defined as Complete response (CR), partial response (PR) or stable disease (SD) of the treated site(s). Complete response is the disappearance of the target lesion. Partial response is a \>/= 50% decrease in maximal dimension compared to pretreatment imaging. Stable disease does not qualify for CR, PR, or progression. Progression is an interval increase in the maximal dimension of the target lesion.
groups
  1. description
    Patients undergo hypofractionated highly conformal radiotherapy with helical tomotherapy once every other day over 5 days for a total of 3 fractions.
    id
    OG000
    title
    Radiation Therapy in Metastatic Cancer
population Description
No data/specimens were collected. Study was terminated due to poor accrual.
reporting Status
POSTED
time Frame
12 months
title
12 Month Local Control in All Sites of Treatment, and at Each Site of Treatment
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice